News

PFS in Phase 3 HARMONi study was met with statistical significance, but OS was not. Click here to find out why SMMT stock is ...
The Real Brokerage Inc. (NASDAQ: REAX), a technology platform reshaping real estate for agents, home buyers, and sellers, ...
Android 17 will be coming in 2026, but we already know a fair bit of what's coming with the upcoming Android platform update ...
Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, today announced that its LearnGov platform has achieved ...
LUND, SE / ACCESS Newswire / May 26, 2025 / Alligator Bioscience (STO:ATORX) NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, ...
Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...
LYTENAVATM is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Un ...
Newly-elevated interim Capitol Police Chief Sean Gallagher faced a whistleblower complaint and a "no-confidence" vote over ...
Suspect in firebombing of Israeli hostages march is in US ‘illegally’ - Suspect shouting ‘Free Palestine!’ carried out ...
The pharmaceutical testing lab BRS Analytical Service recalled products used to relieve dry and irritated eyes after "deviations" were found in adhering to FDA safety regulations.